The Relationship Between Posture, Sense of Position, Musculoskeletal Discomfort and Anxiety

April 7, 2024 updated by: Ankara Yildirim Beyazıt University

The Relationship Between Posture, Sense of Position, Musculoskeletal Discomfort and Anxiety in Asymptomatic Individuals: A Cross-Sectional Study

It is known that posture is affected by various factors such as somatosensation, visual perception and cognition. In addition, it is also thought to affect conditions such as stress and anxiety through receptors. The aim of this study was to investigate the relationship between postural changes such as thoracic kyphosis, musculoskeletal problems, trunk position sense and anxiety in young individuals who were asymptomatic in terms of musculoskeletal problems.

Study Overview

Study Type

Observational

Enrollment (Actual)

67

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey
        • Ankara Yıldırım Beyazıt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Young people who are asymptomatic in terms of musculoskeletal problems

Description

Inclusion Criteria:

  • 18 years and older
  • Volunteered to participate in the study
  • No systemic or neurological disease

Exclusion Criteria:

  • Severe visual and hearing problems
  • Orthopedic injury or surgery in the last 6 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1
The only group of this cross-sectional observational study consists of individuals over the age of 18. There were no orthopedic and neurological chronic diseases included. Individuals with severe visual and hearing problems and individuals who had undergone surgery within the last 6 months were excluded.
No intervention was applied to the group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Throcic Kyphosis
Time Frame: Baseline
The thoracic kyphosis angle was evaluated with a dual digital inclinometer (Acumar, Lafeyette, USA). Repetitive cervical flexion, extension and lateral flexion movements were asked from the subjects before the measurement. They were also asked to perform back rotation of the shoulders and to take a deep breath in and out. Subsequently, they were asked to stand in a normal position in which they were comfortable and the measurement was performed. The inclinometer was placed on the T1-2 and T12-L1 vertebrae. The value on the inclinometer screen was noted as the degree of kyphosis. A kyphosis angle of 20-40 degrees is considered normal. Values above 45 degrees are considered as hyperkyphosis.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trunk Position Sense
Time Frame: Baseline
Trunk position sense was evaluated with a dual digital inclinometer (Acumar, Lafeyette, USA) during 30 degrees of trunk flexion. For the measurement, the subjects were asked to stand in a standing and comfortable position. The inclinometer was placed on the T1 and S1 vertebrae. Individuals were asked to perform 30 degrees of trunk flexion with their eyes closed. The measurement was taught by performing 2 trials. Then, the individuals were asked to find the target angle that was taught. The angle that the individuals thought was the target angle was recorded. The difference between the recorded angle and the target angle was written as absolute value. The process was repeated three times and averaged. There is no specific reference value for trunk flexion position sensation.
Baseline
Musculoskeletal Discomfort
Time Frame: Baseline
Musculoskeletal disorders of the individuals were assessed with the Cornell Musculoskeletal Disorder Scale. The scale consists of three categories assessing the frequency, severity and work intervention of musculoskeletal discomfort in 20 different body parts within a week. The answers given in the frequency section are scored between 0-1.5-3.5-5-10. In the severity of musculoskeletal discomfort and the work disability caused by the musculoskeletal system disorder sections the answers are scored between 1-3. The scores for each body part are multiplied and then summed to obtain a total score from the three sections. The total score is the sum of all section scores. A lower score indicates less musculoskeletal discomfort.
Baseline
Anxiety
Time Frame: Baseline
Anxiety of the individuals was assessed with the Generalised Anxiety Disorder-7 scale. The scale evaluates the experiences in the last 2 weeks. The Generalised Anxiety Disorder-7 scale is a four-point Likert-type scale based on self-report. The total score is obtained by adding the score of the answer given to each item. The higher the total score obtained from the scale, the higher the level of anxiety.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 30, 2022

Primary Completion (Actual)

November 30, 2022

Study Completion (Actual)

December 30, 2022

Study Registration Dates

First Submitted

April 7, 2024

First Submitted That Met QC Criteria

April 7, 2024

First Posted (Actual)

April 11, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2024

Last Update Submitted That Met QC Criteria

April 7, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-874/08

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on No intervention

Subscribe